Trump’s Drug Pricing Deals Now Cover 26 Companies
President Trump announced Monday that nine more pharmaceutical companies have agreed to his “Most Favored Nation” drug pricing framework, bringing the total to 26 manufacturers the White House says now cover 89% of the branded drug market. The new agreements involve mid-sized companies, including Astellas, BeOne Medicines, CSL, BridgeBio, Sun Pharmaceutical, Teva and UCB, which … Read more
